A review of issues surrounding quality of life among women with ovarian cancer

Gynecologic Oncology

Volumn 119, Issue 2, 2010, Pages 390-396

  Arriba, Lucybeth Nieves ^a   Fader, Amanda Nickles ^b   Frasure, Heidi E ^c   Von Gruenigen, Vivian E ^d  

^a LERNER RESEARCH INSTITUTE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d SUMMA HEALTH SYSTEM   (United States)

Author keywords

Ovarian cancer; Quality of life; Quality of life tools

Indexed keywords

ALTERNATIVE MEDICINE; CANCER STAGING; CAREGIVER; CLINICAL PRACTICE; DATA BASE; FATIGUE; FEMALE; HEALTH SURVEY; HUMAN; NUTRITION; OVARY CANCER; PALLIATIVE THERAPY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT CANCER; REVIEW; SUPPORT GROUP; WELLBEING; OVARY TUMOR; PATHOPHYSIOLOGY; PSYCHOLOGY;

FEMALE; HUMANS; OVARIAN NEOPLASMS; QUALITY OF LIFE;

EID: 77957755013     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.05.014     Document Type: Review

References (60)

1. Ovarian cancer: Nacional Cancer Institute. Available at http://www.cancer.gov/cancertopics/types/ovarian/. Accessed October 15, 2009.
2. D.F. Cella, D.S. Tulsky, and G. Gray The Functional Assessment of Cancer Therapy (FACT) scale: development and validation of the general measure J. Clin. Oncol. 11 1993 570 579
3. FACIT: View questionnaires and availability. Available at http://www.facit.org/qview/qlist.aspx. Accessed October 15, 2009.
4. K. Basen-Engquist, D. Bodurka-Bevers, and M.A. Fitzgerald Reliability and validity of the functional assesment of cancer therapy-ovarian J. Clin. Oncol. 19 2001 1809 1817
5. J.E. Brazier, R. Harper, and N.M. Jones Validating the SF-36 health survey questionnaire: new outcome measure for primary care BMJ 305 1992 160 164
6. E. Greimel, A. Bottomley, and A. Cull An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer Eur. J. Cancer 39 2003 1402 1408
7. J. Waterhouse, and M.C. Metcalfe Development of the sexual adjustment questionnaire Oncol. Nurs. Forum 13 1986 53 59
8. L.B. Wenzel, H.Q. Huang, and D.K. Armstrong Gynecologic Oncology Group. Health-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: a Gynecologic Oncology Group Study J. Clin. Oncol. 25 2007 437 443
9. L. Wenzel, H.Q. Huang, and B.J. Monk Quality of life comparisons in a randomized trial of interval secondary cytoreduction in advanced ovarian carcinoma: a Gynecology Oncology Group study J. Clin. Oncol. 23 2005 5605 5612
10. Cain E.N. Kohorn, and Quinlan D.M. EI Psychosocial reactions to the diagnosis of gynecologic cancer Obstet. Gynecol. 62 1983 635 641
11. D.R. Zacharias, C.A. Gilg, and M.J. Foxall Quality of life and coping in patients with gynecologic cancer and their spouses Oncol. Nurs. Forum 21 1994 1699 1706
12. F. Guidozzi Living with ovarian cancer Gynecol. Oncol. 50 1993 202 207
13. A.B. Kornblith, H.T. Thaler, and G. Wong Quality of life of women with ovarian cancer Gynecol. Oncol. 59 1995 231 242
14. R.T. Penson, L.B. Wenzel, and I. Vergote Quality of life considerations in gynecologic cancer Int. J. Gynaecol. Obstet. 95 2006 S247 S257
15. B. Ferrell, C.A. Cullinane, and K. Ervine Perspectives on the impact of ovarian cancer: women's views of quality of life Oncol. Nurs. Forum 32 2005 1143 1149
16. K.L. Mirabeau-Beale, A.B. Kornblith, and R.T. Penson Comparison of the quality of life of early and advanced stage ovarian cancer survivors Gynecol. Oncol. 114 2009 353 359
17. L.B. Wenzel, J.P. Donnelly, and J.M. Fowler Resilience, reflection, and residual stress in ovarian cancer survivorship: a gynecologic oncology group study Psychooncology 11 2002 142 153
18. J.D. Wright, M. Shah, and L. Mathew Fertility preservation in young women with epithelial ovarian cancer Cancer 115 2009 4118 4126
19. U.A. Matulonis, A. Kornblith, and H. Lee Long term adjustment of early stage ovarian cancer survivors Int. J. Gynecol. Cancer 18 2008 1183 1193
20. V.E. von Gruenigen, H.E. Frasure, and M. Grandon Longitudinal assessment of quality of life and lifestyle in newly diagnosed ovarian cancer patients: the roles of surgery and chemotherapy Gynecol. Oncol. 103 2006 120 126
21. A. du Bois, H.J. Lück, and W. Meier A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment for ovarian cancer J. Natl Cancer Inst. 95 2003 1320 1329
22. M.S. Carey, M. Bacon, and D. Tu The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer Gynecol. Oncol. 108 2008 100 105
23. A. Bezjak, D. Tu, and M.J. Bacon Quality of life in ovarian cancer patients: comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized study Clin. Oncol. 22 2004 4595 4603
24. V.E. von Gruenigen, H.Q. Huang, and K.M. Gil Assessment of factors that contribute to decreased quality of life in Gynecologic Oncology Group ovarian cancer trials Cancer 115 2009 4857 4864
25. T. Le, L. Hopkins, and M.F. Kee Fung Quality of life assessment during adjuvant and salvage chemotherapy for advance stage epithelial ovarian cancer Gynecol. Oncol. 98 2005 39 44 (Pubitemid 40826416)
26. G.J. Rustin, M.E. van der Burg on behalf of MRC and EORTC collaborators A randomized trial in ovarian cancer (OC) of early treatment of relapse based on CA125 level alone versus delayed treatment based on conventional clinical indicators (MRC OV05/EORTC 55955 trials) J. Clin. Oncol. 27 2009 abstr 1
27. C.C. Earle, B.A. Neville, and M.B. Landrum Trends in the aggressiveness of cancer care near the end of life J. Clin. Oncol. 22 2004 315 321
28. V. von Gruenigen, B. Daly, and H. Gibbons Indicators of survival duration in ovarian cancer and implications for aggressiveness of care Cancer 112 2008 2221 2227
29. K. Houck, N.E. Avis, and J.M. Gallant Quality of life in advanced ovarian cancer: identifying specific concerns J. Palliat. Med. 2 1999 397 402
30. C. Doyle, M. Crump, and M. Pintilie Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer J. Clin. Oncol. 19 2001 1266 1274
31. M. Friedlander, P. Butow, and M. Stockler Symptom control in patients with recurrent ovarian cancer Int. J. Gynecol. Cancer 19 2009 S44 S48
32. A. Caceres, Q. Zhou, and A. Iasonos Colorectal stents for palliation of large bowel obstructions in recurrent gynecologic cancer: an updated series Gynecol. Oncol. 108 2008 482 485
33. N.D. Fleming, A. Alvarez-Secord, and V. von Gruenigen Indwelling catheters for the management of refractory malignant ascites: a systematic literature overview and retrospective chart review J. Pain Symptom Manage. 38 2009 341 349
34. Y.J. Cai, D.Y. Zheng, and R.C. Luo Avastin combined with cisplatin inhibits malignant ascites production in nude mice bearing transplanted ovary carcinoma with high VEGF expression Nan Fang Yi Ke Da Xue Xue Bao 27 2007 647 649
35. C.A. Hamilton, G.L. Maxwell, and M.R. Chernofsky Intraperitoneal bevacizumab for palliation of malignant ascites in refractory ovarian cancer Gynecol. Oncol. 111 2008 530 532
36. T.M. Numnum, R.P. Rocconi, and J. Whitworth The use of bevacizumab to palliate symptomatic ascites in patients with refractory ovarian carcinoma Gynecol. Oncol. 102 2006 425 428
37. J. Weis Support groups for cancer patients Support. Care Cancer 11 2003 63 68
38. A. Bottomley Psychosocial problems in cancer care: a brief review of common problems J. Psychiatr. Ment. Health Nurs. 4 1997 323 331
39. K. Ahlberg, and A. Nordner The importance of participation in support groups for women with ovarian cancer Oncol. Nurs. Forum 33 2006 E53 E61
40. D.E. Steward, S. Duff, and F. Wong The views of ovarian cancer survivors on its cause, prevention, and recurrence Medscape Women's Health 6 2001 5 10
41. A.H. Liavaag, A. Dorum, and T. Bjoro A controlled study of sexual activity and functioning in epithelial ovarian cancer survivors. A therapeutic approach. Gynecol. Oncol. 108 2008 348 354
42. M.L. Stead Lack of communication between healthcare professionals and women with ovarian cancer about sexual issues Br. J. Cancer 88 2003 666 671
43. M.L. Stead Sexual function after treatment for gynecological malignancy Curr. Opin. Oncol. 16 2004 492 495
44. A. Amsterdam, and M.L. Krychman Sexual dysfunction in patients with gynecologic neoplasms: a retrospective pilot study J. Sex. Med. 3 2006 646 649
45. S.K. Lutgendorf, E.L. Johnsen, and B. Cooper Vascular endothelial growth factor and social support in patients with ovarian carcinoma Cancer 95 2002 808 815 (Pubitemid 34839673)
46. E.S. Costanzo, S.K. Lutgendorf, and A.K. Sood Psychosocial factors and interleukin-6 among women with advanced ovarian cancer Cancer 104 2005 305 313
47. T. Le, A. Leis, and P. Pahwa Quality of life evaluations of caregivers of ovarian cancer patient during chemotherapy treatment J. Obstet. Gynaecol. Can. 26 2004 627 631
48. E. Maunsell, M. Drolet, and J. Brisson Dietary change after breast cancer: extent, predictors, and relation with psychological distress J. Clin. Oncol. 20 2002 1017 1025
49. C.M. Blanchard, F. Baker, and M.M. Denniston Is absolute amount or change in exercise more associated with quality of life in adult cancer survivors? Prev. Med. 37 2003 389 395
50. C.L. Rock, and W. Demark-Wahnefried Can lifestyle modification increase survival in women diagnosed with breast cancer? J. Nutr. 132 2002 3504S 3507S
51. K.S. Courneya, J.R. Mackey, and G.J. Bell Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes J. Clin. Oncol. 21 2003 1660 1668
52. C. Stevinson, W. Faught, and H. Steed Association between physical activity and quality of life in ovarian cancer Gynecol. Oncol. 106 2007 244 250
53. C. Stevinson, H. Steed, and W. Faught Physical activity in ovarian cancer survivors: associations with fatigue, sleep, and psychosocial functioning Int. J. Gynecol. Cancer 19 2009 73 78
54. C. Stevinson, V. Capstick, and A. Schepansky Physical activity preferences of ovarian cancer survivors Psycho-Oncology 18 2009 422 428
55. S.C. Danhaue, J.A. Tooze, and D.F. Farmer Restorative yoga for women with ovarian or breast cancer: findings from a pilot study L Soc. Integr. Oncol. 6 2008 47 58
56. R.T. Chlebowski, G.L. Blackburn, and C.A. Thomson Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study J. Natl Cancer Inst. 98 2006 1767 1776
57. C.M. Nagle, D.M. Purdie, and P.M. Webb Dietary influences on survival after ovarian cancer Int. J. Cancer 106 2003 264 269
58. P. Ravasco, I. Monteiro-Grillo, and P.M. Vidal Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy J. Clin. Oncol. 23 2005 1431 1438
59. W. Demark-Wahnefried, B.L. Peterson, and E.P. Winer Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy J. Clin. Oncol. 19 2001 2381 2389
60. C.M. Mueller, P.L. Mai, and J. Bucher Complementary and alternative medicine use among women at increased genetic risk of breast and ovarian cancer BMC Complement. Altern. Med. 30 2008 17 26